Kardium Inc.’s Post

Kardium Inc. reposted this

View organization page for Kardium Inc., graphic

10,656 followers

Thanks Christopher Woods, MD PhD for sharing your positive thoughts on our clinical data. We are also looking forward to sharing the exciting results of the PULSAR study.

View organization page for Kardium Inc., graphic

10,656 followers

Exciting clinical results from the PULSE-EU study of the Globe System presented today at #HRS2024 84.2 % freedom from Atrial Arrhythmia 0% Major adverse events* 23 minutes average to isolate all pulmonary veins 1.2 average applications per vein #Globe #AFib #epeeps * Major adverse events: Stroke, thromboembolism, pericardial effusion, esophageal fistula, phrenic nerve paralysis, PV stenosis, major vascular complications

To view or add a comment, sign in

Explore topics